Abstract
Metabolic Engineering (ME) provides the know-how for the reconstruction of microorganisms, in order to provide higher production rates of biotechnological products and increase their potential application in several industries, particularly those pharmaceutical, food and environmental. However, microbial metabolic cell reconstruction has limitations. Metabolic Control Analysis (MCA) allows the evaluation of the reliability of the changes performed by ME, emphasizing the importance of the whole pathways rather than individual pathway reactions resulting from simple flux analysis. This led to an increased emphasis on the regulatory structure of the network. The use of MCA becomes indispensable to quantify metabolic parameters, particularly those related with direct genetic modifications. However, this type of analysis is not a common practice. In the present study MCA is exemplified as a tool of ME, being demonstrated its practical application in drug delivery and in the production of three relevant biotechnological products (penicillin V, llysine and glycerol).
Keywords: Control coefficient, drug delivery, enzyme, glycerol, kinetics, l-lysine, metabolic control analysis, penicillin V.
Current Bioinformatics
Title:Metabolic Control Analysis and its Applications
Volume: 9 Issue: 5
Author(s): Ana Meireles and Manuel Simoes
Affiliation:
Keywords: Control coefficient, drug delivery, enzyme, glycerol, kinetics, l-lysine, metabolic control analysis, penicillin V.
Abstract: Metabolic Engineering (ME) provides the know-how for the reconstruction of microorganisms, in order to provide higher production rates of biotechnological products and increase their potential application in several industries, particularly those pharmaceutical, food and environmental. However, microbial metabolic cell reconstruction has limitations. Metabolic Control Analysis (MCA) allows the evaluation of the reliability of the changes performed by ME, emphasizing the importance of the whole pathways rather than individual pathway reactions resulting from simple flux analysis. This led to an increased emphasis on the regulatory structure of the network. The use of MCA becomes indispensable to quantify metabolic parameters, particularly those related with direct genetic modifications. However, this type of analysis is not a common practice. In the present study MCA is exemplified as a tool of ME, being demonstrated its practical application in drug delivery and in the production of three relevant biotechnological products (penicillin V, llysine and glycerol).
Export Options
About this article
Cite this article as:
Meireles Ana and Simoes Manuel, Metabolic Control Analysis and its Applications, Current Bioinformatics 2014; 9 (5) . https://dx.doi.org/10.2174/1574893609666140515230435
DOI https://dx.doi.org/10.2174/1574893609666140515230435 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Microfluidic Control of Hypoxia Aids Investigations of Islet Pathophysiology
Micro and Nanosystems The Potential Roles of Gamma-Glutamyltransferase Activity in the Progression of Atherosclerosis and Cardiovascular Diseases
Vascular Disease Prevention (Discontinued) Study of Cord Blood Levels of Erythropoietin, Bilirubin and Reticulocyte Count as Early Predictors of Neonatal Hyperbilirubinemia
Endocrine, Metabolic & Immune Disorders - Drug Targets Promising Pharmacological, Molecular and Cellular Treatments of Autoimmune Hepatitis
Current Pharmaceutical Design Molecularly Imprinted Polymer of Colocynthin, An Effective Tool for Quality Control of <i>Citrullus colocynthis</i> Extracts
Current Drug Discovery Technologies Long Term Cardiovascular Risk in Women
Vascular Disease Prevention (Discontinued) Editorial [Hot Topic:Dietary Determinants of the Metabolic Syndrome (Guest Editor: Luc Tappy Co-Editors: Jacques Delarue and Kim-Anne Le)]
Current Nutrition & Food Science Inflammation, Adiponectin, Obesity and Cardiovascular Risk
Current Medicinal Chemistry GST T1, M1, and IRS-1 G972R Genetic Variants Association to Gestational Diabetes Mellitus (GDM) in Egyptian Women: Linkage to Maternal Hyperglycemia
Current Diabetes Reviews Editorial (Point-of-Care Technologies and their Global Health Applications)
Current Pharmacogenomics and Personalized Medicine Association of DRD2 TaqIA and DβH -1021C>T Gene Polymorphisms with Smoking Initiation and their Interaction with Serotonergic System Gene Polymorphisms
Current Pharmacogenomics and Personalized Medicine Application of Diet-derived Taste Active Components for Clinical Nutrition: Perspectives from Ancient AyurvedicMedical Science, Space Medicine, and Modern Clinical Nutrition
Current Pharmaceutical Design Statin-Induced Myotoxicity: Pharmacokinetic Differences among Statins and the Risk of Rhabdomyolysis, with Particular Reference to Pitavastatin
Current Vascular Pharmacology Derivatives of Resveratrol: Potential Agents in Prevention and Treatment of Cardiovascular Disease
Current Medicinal Chemistry Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimers Disease
Current Alzheimer Research Type 1 Diabetes Treatments Based on Stem Cells
Current Diabetes Reviews Novel Non-Steroidal Anti-Inflammatory Drugs: What we have Learned from Animal Studies
Current Drug Targets - Inflammation & Allergy Nutrigenomics and its Impact on Life Style Associated Metabolic Diseases
Current Genomics Antidotal Effects of Curcumin Against Agents-Induced Cardiovascular Toxicity
Cardiovascular & Hematological Disorders-Drug Targets Glycation and Hypoxia: Two Key Factors for Adipose Tissue Dysfunction
Current Medicinal Chemistry